https://orcid.org/0000-0002-7135-3909
References
- Apaza Ticona L, Rodríguez Coballes M, Potente G, Rumbero A. 2020a. Anti-inflammatory potential of macamides isolated from yellow tubers of Mashua (Tropaeolum Tuberosum. Planta Med Int Open. 07(03):e88–e99.
- Apaza Ticona L, Tena Pérez V, Serban AM, Sánchez-Corral J, Rumbero A. 2020c. Design, synthesis and pharmacological evaluation of N-benzyl linoleamide analogues from Tropaeolum tuberosum as NF-κB inhibitors and Nrf2 activators. Chem Select. 5:11825–11836.
- Apaza Ticona L, Tena Pérez V, Bermejo Benito P. 2020b. Local/traditional uses, secondary metabolites and biological activities of Mashua (Tropaeolum tuberosum Ruíz & Pavón). J Ethnopharmacol. 247:112152.
- Apaza Ticona L, Tena Pérez V, Serban AM, Alonso Navarro MJ, Rumbero A. 2019. Alkamides from Tropaeolum tuberosum inhibit inflammatory response induced by TNF-α and NF-κB. J Ethnopharmacol. 235:199–205.
- Arnott JA, Planey SL. 2012. The influence of lipophilicity in drug discovery and design. Expert Opin Drug Discov. 7(10):863–875.
- D'Oca CDRM, Coelho T, Marinho TG, Hack CRL, Duarte R. d C, da Silva PA, D'Oca MGM. 2010. Synthesis and antituberculosis activity of new fatty acid amides. Bioorg Med Chem Lett. 20(17):5255–5257.
- Davis KE, Prasad C, Vijayagopal P, Juma S, Imrhan V. 2016. Advanced Glycation End Products, Inflammation, and Chronic Metabolic Diseases: Links in a Chain? Crit Rev Food Sci Nutr. 56: 989–998.
- Fadul E, Nizamani A, Rasheed S, Adhikari A, Yousuf S, Parveen S, Gören N, Alhazmi HA, Choudhary MI, Khalid A. 2020. Anti-glycating and anti-oxidant compounds from traditionally used anti-diabetic plant Geigeria alata(DC) Oliv. & Hiern. Nat Prod Res. 34(17):2456–2464.
- Li Y, Chang Y, Ye N, Chen Y, Zhang N, Sun Y. 2017. Advanced glycation end products‑induced mitochondrial energy metabolism dysfunction alters proliferation of human umbilical vein endothelial cells. Mol Med Rep. 15(5):2673–2680.
- Liu M, Tang F, Liu Q, Xiao J, Cao H, Chen X. 2020. Inhibition of resveratrol glucosides (REs) on advanced glycation endproducts (AGEs) formation: inhibitory mechanism and structure-activity relationship. Nat Prod Res. 34(17):2490–2494.
- Ramasamy R, Yan SF, Herold K, Clynes R, Schmidt AM. 2008. Receptor for advanced glycation end products: fundamental roles in the inflammatory response: winding the way to the pathogenesis of endothelial dysfunction and atherosclerosis. Ann N Y Acad Sci. 1126:7–13.
- Xin C, Wang Y, Liu M, Zhang B, Yang S. 2021. Correlation analysis between advanced glycation end products detected noninvasively and skin aging factors. J Cosmet Dermatol. 20(1):243–248.
- Yamagishi S, Nakamura K, Matsui T, Ueda S, Noda Y, Imaizumi T. 2008. Inhibitors of advanced glycation end products (AGEs): potential utility for the treatment of cardiovascular disease. Cardiovasc Ther. 26(1):50–58.
- Yan D, Yang Q, Shi M, Zhong L, Wu C, Meng T, Yin H, Zhou J. 2013. Polyunsaturated fatty acids promote the expansion of myeloid-derived suppressor cells by activating the JAK/STAT3 pathway. Eur J Immunol. 43(11):2943–2955.
- Ye YQ, Ma ZH, Yang QF, Sun YQ, Zhang RQ, Wu RF, Ren X, Mu LJ, Jiang ZY, Zhou M. 2019. Isolation and synthesis of a new benzylated alkamide from the roots of Lepidium meyenii. Nat Prod Res. 33(19):2731–2737.